Earnings History Data for Geron Corporation (GERN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Geron Corporation

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		GERN	Geron Corporation	2,540	-0.04	-0.09	-0.08	Geron GAAP EPS of -$0.04 beats by $0.05 [11/7/2024 7:04 AM]	4.30	0.03 (0.67%)	4.45	0.18 (4.22%)	1.64 - 5.34	34,679,650	6,530,000	1,947,359
Geron Q3 2024 Earnings Preview [11/6/2024 3:26 PM] Geron GAAP EPS of -$0.04 beats by $0.05 [11/7/2024 7:04 AM] Geron spikes after Q3 beat and $375M funding deal [11/7/2024 7:34 AM] Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors [2024-11-07 07:01AM] Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million [2024-11-07 07:10AM] Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights [2024-11-07 07:00AM]
08-08-2024	PM		GERN	Geron Corporation	2,730	-0.10	-0.11	-0.09	Geron GAAP EPS of -$0.10 in-line, revenue of $0.88M beats by $0.59M [8/8/2024 7:06 AM]	4.58	0.02 (0.44%)	4.44	-0.12 (-2.63%)	1.64 - 5.34	12,301,047	12,620,000	34,381
Geron Q2 2024 Earnings Preview [8/7/2024 11:14 AM] Geron GAAP EPS of -$0.10 in-line, revenue of $0.88M beats by $0.59M [8/8/2024 7:06 AM]
02-05-2024	PM		GERN	Geron Corporation	2,260	-0.09	-0.10	-0.07	Geron GAAP EPS of -$0.09 beats by $0.01 [5/2/2024 7:08 AM]	3.94	-0.15 (-3.55%)	4.13	0.05 (1.25%)	1.64 - 4.30	8,800,217	11,710,000	41,205
Geron GAAP EPS of -$0.09 beats by $0.01 [5/2/2024 7:08 AM] Geron Q1 2024 Earnings Preview [5/1/2024 11:38 AM]
28-02-2024	PM		GERN	Geron	1,064	-0.09	-0.10	0.00	Geron GAAP EPS of -$0.09 beats by $0.01 [2/28/2024 7:08 AM]	1.95	-0.12 (-5.81%)	2.12	0.06 (2.66%)	1.68 - 3.73	12,484,758	7,470,000	19,805
Geron Q4 2023 Earnings Preview [2/27/2024 1:21 PM] Geron GAAP EPS of -$0.09 beats by $0.01 [2/28/2024 7:08 AM]
02-11-2023	PM		GERN	Geron Corporation	994.40	-0.08	-0.10	-0.10	Geron GAAP EPS of -$0.08 beats by $0.02, revenue of $0.16M beats by $0.09M [11/2/2023 8:03 AM]	1.78	-0.15 (-7.77%)	1.78	0.0 (0.00%)	1.73 - 3.84	5,451,055	4,140,000	7,925
Geron Q3 2023 Earnings Preview [11/1/2023 1:01 PM] Geron GAAP EPS of -$0.08 beats by $0.02, revenue of $0.16M beats by $0.09M [11/2/2023 8:03 AM]
03-08-2023	AH		GERN	Geron Corporation	1,630	-0.09	-0.08	-0.07	Geron GAAP EPS of -$0.29 misses by $0.20 [8/3/2023 4:35 PM]	2.96	-0.20 (-6.17%)	3.06	-0.10 (-3.16%)	1.95 - 3.84	7,213,859	2,610,000	5,170
Geron GAAP EPS of -$0.29 misses by $0.20 [8/3/2023 4:35 PM]
11-05-2023	PM	8:00 AM ET (May 11)	GERN	Geron Corporation	1,430	-0.07	-0.09	-0.09	Geron GAAP EPS of -$0.07 beats by $0.03 [5/11/2023 8:04 AM]	2.90	0.08 (2.84%)	2.81	-0.01 (-0.35%)	1.18 - 3.84	5,646,158	4,240,000	17,518
Geron GAAP EPS of -$0.07 beats by $0.03 [5/11/2023 8:04 AM] Geron preps for commercial launch of blood cancer therapy [5/11/2023 9:01 AM]
16-03-2023	AH	After the close (Mar 16)	GERN	Geron Corporation	1,270	-0.10	-0.11	-0.10	Geron GAAP EPS of -$0.10 beats by $0.03, revenue of $0.1M misses by $0.02M [3/16/2023 4:07 PM]	2.50	-0.15 (-5.47%)	2.60	-0.05 (-1.89%)	1.02 - 3.84	8,674,050	5,050,000	10,250
Geron GAAP EPS of -$0.10 beats by $0.03, revenue of $0.1M misses by $0.02M [3/16/2023 4:07 PM]
03-11-2022	PM	0:00 AM ET (Nov 3)	GERN	Geron Corporation	812.31	-0.10	-0.09	-0.08	Geron GAAP EPS of -$0.10 misses by $0.01, revenue of $0.3M beats by $0.21M [11/3/2022 8:13 AM]	2.06	-0.09 (-4.42%)	2.18	0.03 (1.40%)	0.99 - 3.06	3,281,994	4,020,000	5,626
Geron GAAP EPS of -$0.10 misses by $0.01, revenue of $0.3M beats by $0.21M [11/3/2022 8:13 AM] Geron posts wider-than- expected Q3 loss [11/3/2022 11:45 AM] Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones [Nov-03-22 08:00AM]
11-08-2022	AH	4:05 PM ET (Aug 11)	GERN	Geron Corporation	679.40	-0.07	-0.09	-0.09	Geron GAAP EPS of -$0.07 beats by $0.02, revenue of $0.07M misses by $0.04M [8/11/2022 4:07 PM]	2.33	0.28 (13.90%)	2.15	0.10 (4.88%)	0.99 - 2.67	4,402,594	4,770,000	14,929
Geron GAAP EPS of -$0.07 beats by $0.02, revenue of $0.07M misses by $0.04M [8/11/2022 4:07 PM] Geron rises on narrower-than-expected Q2 loss [8/12/2022 10:45 AM] Top Penny Stocks for August 2022 [Aug-11-22 01:27PM] Allogene (ALLO) Q1 Earnings Beat, Pipeline Progressing Well [Aug-10-22 02:54PM]
09-05-2022	AH	4:05 PM ET (May 9)	GERN	Geron Corporation	527.89	-0.09	-0.11	-0.09	Geron GAAP EPS of -$0.09 beats by $0.01, revenue of $0.12M beats by $0.02M [5/9/2022 4:14 PM]	1.47	0.24 (19.52%)	1.25	0.02 (1.63%)	0.99 - 2.23	2,730,829	2,347,895	1,629
Geron GAAP EPS of -$0.09 beats by $0.01, revenue of $0.12M beats by $0.02M [5/9/2022 4:14 PM] Geron Corporation Reports First Quarter 2022 Financial Results [May-09-22 04:05PM] Geron (GERN) Q1 2022 Earnings Call Transcript [May-10-22 02:09AM] Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates [May-09-22 05:55PM] Why Geron Stock Is Soaring Today [May-10-22 12:21PM]
10-03-2022	AH	6:00 PM ET (Mar 10)	GERN	Geron Corporation	334.83	-0.10	-0.08	-0.07	Geron GAAP EPS of -$0.10 misses by $0.02, revenue of $1M beats by $0.94M [3/10/2022 4:49 PM]	1.10	0.01 (0.45%)	1.10	0.0 (0.00%)	0.99 - 2.23	1,324,081	1,460,000	12,607
Geron GAAP EPS of -$0.10 misses by $0.02, revenue of $1M beats by $0.94M [3/10/2022 4:49 PM] Geron Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Milestones [Mar-10-22 04:06PM] Geron (GERN) Q4 2021 Earnings Call Transcript [Mar-10-22 09:00PM]
09-11-2021	PM		GERN	Geron	529.00	-0.08	-0.09	0.00	Geron EPS beats by $0.01, beats on revenue [11/10/2021 8:46 AM]	1.55	-0.13 (-7.74%)	1.57	-0.11 (-6.55%)	1.20 - 2.35	2,325,079	2,300,000	66,819
Geron EPS beats by $0.01, beats on revenue [11/10/2021 8:46 AM] Geron slips despite quarterly EPS, revenue beat [11/10/2021 2:01 PM] Geron Presents Investor Event Highlights [Nov-09-21 06:00PM] Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 09:05PM]
16-08-2021	AH	4:05 PM ET (Aug 16)	GERN	Geron Corporation	391.84	-0.09	-0.09	-0.06	Geron EPS in-line, beats on revenue [8/16/2021 4:07 PM]	1.27	0.08 (6.25%)	1.20	0.0 (0.00%)	1.20 - 2.35	2,617,182	1,700,000	28,070
Geron EPS in-line, beats on revenue [8/16/2021 4:07 PM] Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023 [Aug-16-21 04:06PM] Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates [Aug-16-21 05:25PM] Geron (GERN) Q2 2021 Earnings Call Transcript [Aug-17-21 05:00AM] The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business [Aug-17-21 08:28AM]
10-05-2021	AH	4:10 PM ET (May 10)	GERN	Geron Corporation	426.83	-0.09	-0.08	-0.08	Geron EPS misses by $0.01, beats on revenue [5/10/2021 4:06 PM]	1.40	0.15 (12.00%)	1.22	-0.03 (-2.40%)	1.22 - 2.40	2,429,611	1,690,000	19,595
Geron EPS misses by $0.01, beats on revenue [5/10/2021 4:06 PM] Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights [May-10-21 04:05PM] Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 05:55PM] Geron (GERN) Q1 2021 Earnings Call Transcript [May-11-21 02:01AM]
11-03-2021	AH	4:05 PM ET (Mar 11)	GERN	Geron Corporation	549.54	-0.07	-0.07	-0.15	Geron EPS in-line, beats on revenue [3/11/2021 4:17 PM]	1.70	-0.19 (-9.95%)	1.77	-0.12 (-6.35%)	0.75 - 2.40	6,507,602	3,411,058	68,885
Geron EPS in-line, beats on revenue [3/11/2021 4:17 PM] Geron's Earnings Outlook [Mar-10-21 10:08AM] Influencers with Andy Serwer: Walter Isaacson [Mar-11-21 07:00AM] Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights [Mar-11-21 04:10PM] Geron (GERN) Q4 2020 Earnings Call Transcript [Mar-12-21 03:00AM] Gene editing will boost intelligence within a few decades [Mar-12-21 08:00AM] Why Geron Corporation Stock Is Falling Today [Mar-12-21 12:06PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	GERN	Geron Corporation	555.74	-0.06	-0.05	-0.08	Geron EPS in-line, beats on revenue [11/5/2020 4:16 PM]	1.78	-0.06 (-3.01%)	1.83	0.0 (0.00%)	0.75 - 2.40	1,455,423	1,682,665	5,427

06-08-2020	AH	4:05 PM ET (Aug 6)	GERN	Geron Corporation	549.35	-0.06	-0.06	-0.08	Geron EPS in-line, misses on revenue [8/6/2020 4:12 PM]	1.67	0.01 (0.60%)	1.62	-0.04 (-2.42%)	0.75 - 2.40	2,273,310	2,329,235	46,504

28-05-2020	AH		GERN	Geron Corporation	368.67	-0.08	-0.09	-0.05	Geron EPS beats by $0.04, revenue in-line [5/28/2020 4:07 PM]	1.62	0.02 (0.93%)	1.67	0.06 (3.73%)	0.75 - 2.40	1,928,013	7,017,090	44,682